Most Powerful Women

Behind Pfizer's latest upheaval at the top

December 17, 2013: 5:59 PM ET

Amy Schulman thought she was getting her dream job at Pfizer. Now she's out the door at the world's largest drug company.

schulmanFORTUNE -- Amy Schulman, one of Pfizer's (PFE) star execs and No. 43 on the Fortune Most Powerful Women list, is out of a job.

And the irony is that her dismissal comes just as she expected to vault into a much bigger one.

When I had lunch with Schulman, 53, last Thursday in New York City, she talked about moving from her current position at the drug giant—general counsel and head of its $3.2 billion global healthcare business—to head three units: vaccines, oncology and global healthcare. That trio of businesses would have given her responsibility for more than $8 billion in annual revenue.

Something went awry between Thursday--when Schulman was prepping for a celebratory dinner at Manhattan's elegant Le Bernardin restaurant with her legal team—and 9 a.m. Tuesday, when Pfizer disclosed her departure in a tersely written press release that said her exit is by "mutual agreement."

Did Schulman make a power play that turned out to be fatal? Did her reputation as a consummate self-promoter rub her boss the wrong way? Did she clash with one of her senior colleagues? Whatever the back story, it's clear that Pfizer is losing a fast-rising executive who seemed in pursuit of the top job at the company.

As Schulman explained over our lunch, her career path was unconventional. In 2008, she left law firm DLA Piper, where she was a star litigator earning almost $6 million annually, to join Pfizer, where her initial pay was a sliver of that. More important than the money, though, was her belief that then-CEO Jeff Kindler, a former general counsel at McDonald's (MCD), would give her broad responsibilities beyond legal.

It didn't turn out that way. While Schulman and Kindler got along initially, their relationship soon soured. She played a role in his 2008 ouster, which Fortune detailed in an award-winning 2011 cover story.

Schulman found an advocate in Kindler's successor, Ian Read, who is now Pfizer's chief executive. Read put her in charge of Pfizer Nutrition, while she held onto her post as the company's chief lawyer. A mother of three boys, Schulman juggled her jobs happily--wanting to stay on as general counsel, she admitted, in case she failed as an operator.

She did not fail at operations. She expanded the $2 billion-a-year nutrition business and improved its profitability. Pfizer sold the unit to Nestle (NSRGF) for a stunning $11.85 billion in 2012.

Eager to run a bigger business, Schulman got a plum assignment heading global healthcare, with well-known brands such as Advil, Chapstick and Centrum vitamins. Meanwhile, she ascended to be one of Pfizer's top-paid executives. Her compensation, including options, totaled $5.6 million in 2012, according to Pfizer's proxy.

Pfizer did not return Fortune's phone calls. Amidst Schulman's sudden exit, her intended assignment goes to Albert Bourla, a 20-year Pfizer veteran. He will be group president of Vaccines, Oncology and Consumer Healthcare. Susan Silbermann, meanwhile, is Pfizer's new president and general manager of Global Vaccines.

At a company famous for palace intrigue, there's a deja vu in this latest drama. Speculation about who will someday replace Read as Pfizer's CEO ensues. For now--until the next upheaval, at least--new division chiefs Bourla, Geno Germano, and John Young emerge as the top contenders.

Posted in:
Join the Conversation
Fortune's Most Powerful Women
Fortune's Most Powerful Women For the latest on the most influential women in business, philanthropy, government, and the arts, like us on Facebook.
Guest Posts
Fortune Most Powerful Women Fortune Most Powerful Women The rolodex that redefined power
Profile in The Washington Post
Sheryl Sandberg: Sheryl Sandberg: Don't leave before you leave
COO of Facebook
Wendy Clark Wendy Clark Exec learns firsthand how the homeless live
SVP of the Global Sparkling Brand Center at Coca-Cola
Marissa Mayer's 3 biggest decisions as Yahoo CEO With company stock up over 100% since she began running the company 16 months ago, Mayer reflects on her choices to date. Watch
Chelsea Clinton on running for office: 'I don't know' The vice chairman of the Clinton Foundation talks about her diverse career path and growing up in the spotlight. Watch
About This Author
Pattie Sellers
Pattie Sellers
Senior Editor at Large, Fortune
Executive Director of MPW/Live Content, Time Inc.

Pattie Sellers has written more than 20 Fortune cover stories including "Marissa Mayer: Ready to Rumble at Yahoo," "Muhtar Kent's New Coke," "Oprah's Next Act", "The $100 Billion Woman" (Melinda Gates), and "Gone with the Wind" (Ted Turner). She co-founded Fortune Most Powerful Women and oversees the Fortune MPW Summit, the preeminent gathering of women leaders in business and beyond—and programs such as Fortune MPW Entrepreneurs and the Fortune-U.S. State Department Global Women Leaders Mentoring Partnership. Pattie also develops Live Content across Time Inc. Her blog, Postcards, is about how power players lead and navigate their careers. Pattie won Time Inc.'s prestigious MVP award for her performance in 2012.

Email Pattie Sellers | Welcome to Postcards.
Follow Pattie | email newsletter
MPWomen go Global

The Fortune/U.S. State Department Global Women Leaders Mentoring Partnership brings rising-star women from countries around the world to the U.S. for three-week mentorships with participants of the annual Fortune Most Powerful Women Summit - among them Ursula Burns of Xerox, Laura Lang of Time Inc., Marissa Mayer of Yahoo, and Tory Burch.

Read more

Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Powered by VIP.